The once-powerful producer convicted of rape has been diagnosed with a type of bone marrow cancer, according to multiple ...
Investigators said the unique features of chimeric antigen receptor (CAR) T-cell therapy may warrant novel approaches to cost ...
2h
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...
AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...
AvenCell Therapeutics has secured $112 million in series B funds as the Novo Holdings-backed biotech seeks clinical proof ...
More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic ...
Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?
A 6 year old arkansan battling leukemia was recognized at the 6th annual lift againt leukemia today.T-cell acute ...
Immunotherapies that mobilize a patient's own immune system to fight cancer have become a treatment pillar. These therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback